Eric Nelson
Biopharma biz dev advisor focused on compound licensing agreements #AI #smallmolecules #geneediting #CNS #licensing
🇩🇪🇨🇭🇨🇳🇸🇪🇰🇷🇫🇷
@drannecarpenter.bsky.social
Dedicated to drug discovery, enthralled by science. 5 kids. She. SAB Recursion. Founder SyzOnc. Lab at Broad Institute. Opinions my own.
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@michaelkearse.bsky.social
Asst. Professor of Biological Chemistry & Pharmacology, Center for RNA Biology, The Ohio State University; we study ribosomes & mRNA translation in human biology & disease; advocate for equity & diversity; www.kearselab.org
@bjgreber.bsky.social
Structural biologist. High-resolution imaging of macromolecular assemblies (and landscapes). MRC career development fellow/group leader at the Institute of Cancer Research, London. Views my own.
@richardsever.bsky.social
Co-Founder, bioRxiv and medRxiv. Assistant Director, Cold Spring Harbor Laboratory Press.
@jasonrkelly.bsky.social
co-founder and CEO at Ginkgo Bioworks Former Chair of National Security Commission on Emerging Biotechnology
@cwhelan.bsky.social
Genomics and bioinformatics. Computational Biologist at Broad Institute. Dad. Bostonian.
@jordixiol.bsky.social
Science, history, and drug development | https://vineyardbooks.substack.com/
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
@recursionpharma.bsky.social
Decoding biology to radically improve lives. The industrial revolution of drug discovery is here. Learn more at recursion.com #techbio
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@eturnermd1.bsky.social
Advocate for and researcher on transparency in medical research. Former FDA reviewer of psychotropic drugs back when the FDA was a tougher gatekeeper.
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.